Monitoring heart risk with a wearable sensor in diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a wearable chest sensor (called HEMOTAG) to monitor heart events in people with long-standing Type 2 diabetes who also have heart disease or specific diabetes-related complications. The sensor is worn at home for short periods to catch early signs of heart trouble, aiming to improve personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have had Type 2 diabetes for at least 5 years (whether or not you take insulin).
- You have heart or blood vessel disease (like coronary artery disease, stroke, or peripheral artery disease) — OR — you have one of these diabetes complications: eye disease (retinopathy), kidney disease (low eGFR or protein in urine), nerve damage, or high inflammation (hs-CRP) along with at least two of: high blood pressure (for 6+ months), high LDL cholesterol, obesity, or smoking history.
- You agree to wear a HEMOTAG chest sensor at home at least 3 days a week for 30 days at the start, at 6 months, and after any heart-related hospital stays.
- You are willing to have standard clinic visits and blood tests (NT-proBNP).
- You can provide signed consent and speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
This study tests whether using a smartphone app and a wearable device (like a fitness tracker), along with artificial intelligence (AI), can help people with type 2 diabetes better manage their condition and prevent complications. You would need to provide lifestyle information and use the devices for 3 months.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This study uses a wearable patch to monitor heart-related signs in people with heart conditions. It aims to learn more about how these conditions progress, which could help improve future care.
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.